|
Accueil > Actualité
Roche: Chugai files application for anti-tumor drug in Japan
(CercleFinance.com) - Roche's Chugai said that it has filed for marketing approval of a treatment for extremely rare NTRK fusion-positive solid tumors with Japanese regulators.
The compound has already received an orphan drug designation from the Ministry of Health, Labour and Welfare (MHLW). The drug's efficacy has been evaluated in 54 patients with untreated NTRK fusion-positive solid tumors while safety assessment has been conducted with 355 patients in four trials, Chugai said. Copyright (c) 2018 CercleFinance.com. All rights reserved. |
19/04/2024 18:06
Alstoma conclu un accord avec Knorr-Bremse 19/04/2024 17:30 Danoneen hausse après deux analyses positives 19/04/2024 16:35 TotalEnergiespartenariat avec OK Petroleum aux USA 19/04/2024 16:29 BAE Systemsmodernise une usine de munitions 19/04/2024 16:15 Netflixle titre trébuche après une publication contrastée 19/04/2024 16:09 Bayersigne un contrat de fourniture d'énergie renouvelables Tous les articles sociétés |
